Offen D - Search Results

1

CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology.

Herman S, Djaldetti R, Mollenhauer B, Offen D. Herman S, et al. Among authors: offen d. Brain. 2023 Jan 5;146(1):209-224. doi: 10.1093/brain/awac261. Brain. 2023. PMID: 35881523

2

Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriers.

Achiron A, Pinhas-Hamiel O, Barak Y, Doll L, Offen D, Djaldetti R, Frankel G, Shohat B. Achiron A, et al. Among authors: offen d. Arch Virol. 1996;141(1):147-53. doi: 10.1007/BF01718595. Arch Virol. 1996. PMID: 8629942

3

Levodopa toxicity and apoptosis.

Melamed E, Offen D, Shirvan A, Djaldetti R, Barzilai A, Ziv I. Melamed E, et al. Among authors: offen d. Ann Neurol. 1998 Sep;44(3 Suppl 1):S149-54. doi: 10.1002/ana.410440722. Ann Neurol. 1998. PMID: 9749587 Review.

4

Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S. Vila M, et al. Among authors: offen d. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2837-42. doi: 10.1073/pnas.051633998. Epub 2001 Feb 13. Proc Natl Acad Sci U S A. 2001. PMID: 11226327 Free PMC article.

5

Polymorphism in candidate genes: implications for the risk and treatment of idiopathic Parkinson's disease.

Gilgun-Sherki Y, Djaldetti R, Melamed E, Offen D. Gilgun-Sherki Y, et al. Among authors: offen d. Pharmacogenomics J. 2004;4(5):291-306. doi: 10.1038/sj.tpj.6500260. Pharmacogenomics J. 2004. PMID: 15224083 Review.

6

Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease.

Sadan O, Shemesh N, Barzilay R, Dadon-Nahum M, Blumenfeld-Katzir T, Assaf Y, Yeshurun M, Djaldetti R, Cohen Y, Melamed E, Offen D. Sadan O, et al. Among authors: offen d. Exp Neurol. 2012 Apr;234(2):417-27. doi: 10.1016/j.expneurol.2011.12.045. Epub 2012 Jan 20. Exp Neurol. 2012. PMID: 22285250

7

Harnessing neurogenesis for the possible treatment of Parkinson's disease.

Lamm O, Ganz J, Melamed E, Offen D. Lamm O, et al. Among authors: offen d. J Comp Neurol. 2014 Aug 15;522(12):2817-30. doi: 10.1002/cne.23607. Epub 2014 May 9. J Comp Neurol. 2014. PMID: 24723264 Review.

8

Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B.

Perets N, Oron O, Herman S, Elliott E, Offen D. Perets N, et al. Among authors: offen d. Mol Autism. 2020 Aug 17;11(1):65. doi: 10.1186/s13229-020-00366-x. Mol Autism. 2020. PMID: 32807217 Free PMC article.

9

Intranasal delivery of mesenchymal stem cells-derived extracellular vesicles for the treatment of neurological diseases.

Herman S, Fishel I, Offen D. Herman S, et al. Among authors: offen d. Stem Cells. 2021 Dec;39(12):1589-1600. doi: 10.1002/stem.3456. Epub 2021 Oct 1. Stem Cells. 2021. PMID: 34520591 Review.

10

Mesenchymal Stem Cell-Derived Extracellular Vesicles as Proposed Therapy in a Rat Model of Cerebral Small Vessel Disease.

Guy R, Herman S, Benyamini H, Ben-Zur T, Kobo H, Pasmanik-Chor M, Yaacobi D, Barel E, Yagil C, Yagil Y, Offen D. Guy R, et al. Among authors: offen d. Int J Mol Sci. 2022 Sep 23;23(19):11211. doi: 10.3390/ijms231911211. Int J Mol Sci. 2022. PMID: 36232513 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters